Cytochrome P-450 CYP2C9 Inhibitors

All categories
DBCAT000489Pharmacologic class

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C9. A DrugBank category of 214 drugs. 187 of them are approved.

Part of
Cytochrome P-450 Enzyme Inhibitors
Also known as
CYP2C9 Inhibitors · CYP2C9 Inhibitors, P450 · Cytochrome P 450 CYP2C9 Inhibitors · Cytochrome P-450 CYP2C9-Inhibitors · Cytochrome P450 2C9 Inhibitors
Drugs

and 189 more with a free account

What you can answer from here — as of September 19, 2019

214DrugsEach linked to its full drug card
Sign in
548Drug targetsEvery drug–target pair in the class, with bond type
Sign in
88,008Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
49Routes of administrationHow the drugs in this class are given
Sign in
4SubcategoriesNarrower classes within this one
Sign in

Which targets do Cytochrome P-450 CYP2C9 Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In